Tech Company Financing Transactions
Aryastha Life Sciences Funding Round
Vessella Group joined a Series A venture round for Aryastha Life Sciences. This venture round was recorded on 8/29/2023.
Transaction Overview
Company Name
Announced On
8/29/2023
Transaction Type
Amount
Unknown
Round
Series A
Investors
Vessella Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate drug discovery and development in the pharmaceutical and biotech sectors.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
Aryastha Life Sciences Private Limited, ARx, Synergy Squar
Shameerpet, Hyderabad, 500078
IN
Shameerpet, Hyderabad, 500078
IN
Phone
Undisclosed
Website
Email Address
Overview
Aryastha was established with the purpose of tackling the common challenges faced by pharmaceutical and biotechnology industries throughout the discovery and developing new drugs. Aryastha stands as the culmination of their transformative journey, spanning multiple years, in addressing scientific challenges across diverse verticals of drug discovery and development. It has evolved into an integrated one-stop-shop solution, embodying their collective expertise and experience. We are uniquely positioned to provide enhanced agility and flexibility in serving our clients, enabling us to expedite the delivery of life-changing medicines to the market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raghava Kethri
Co-Founder
Pradip Majumder
Browse more venture capital transactions:
Prev: 8/29/2023: Jitty venture capital transaction
Next: 8/29/2023: ControlRooms.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs